[go: up one dir, main page]

GB9917384D0 - Chemical compounds-III - Google Patents

Chemical compounds-III

Info

Publication number
GB9917384D0
GB9917384D0 GBGB9917384.1A GB9917384A GB9917384D0 GB 9917384 D0 GB9917384 D0 GB 9917384D0 GB 9917384 A GB9917384 A GB 9917384A GB 9917384 D0 GB9917384 D0 GB 9917384D0
Authority
GB
United Kingdom
Prior art keywords
iii
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917384.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Cerebrus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Ltd filed Critical Cerebrus Ltd
Priority to GBGB9917384.1A priority Critical patent/GB9917384D0/en
Publication of GB9917384D0 publication Critical patent/GB9917384D0/en
Priority to JP2001511908A priority patent/JP2003505413A/en
Priority to PCT/GB2000/002817 priority patent/WO2001007022A2/en
Priority to EP00946187A priority patent/EP1196165A2/en
Priority to AU60060/00A priority patent/AU6006000A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9917384.1A 1999-07-23 1999-07-23 Chemical compounds-III Ceased GB9917384D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9917384.1A GB9917384D0 (en) 1999-07-23 1999-07-23 Chemical compounds-III
JP2001511908A JP2003505413A (en) 1999-07-23 2000-07-21 Azetidine compounds in the CNS and eye diseases
PCT/GB2000/002817 WO2001007022A2 (en) 1999-07-23 2000-07-21 Azetidine compounds in cns and eye diseases
EP00946187A EP1196165A2 (en) 1999-07-23 2000-07-21 Azetidine compounds in cns and eye diseases
AU60060/00A AU6006000A (en) 1999-07-23 2000-07-21 Chemical compounds-iii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917384.1A GB9917384D0 (en) 1999-07-23 1999-07-23 Chemical compounds-III

Publications (1)

Publication Number Publication Date
GB9917384D0 true GB9917384D0 (en) 1999-09-22

Family

ID=10857862

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9917384.1A Ceased GB9917384D0 (en) 1999-07-23 1999-07-23 Chemical compounds-III

Country Status (5)

Country Link
EP (1) EP1196165A2 (en)
JP (1) JP2003505413A (en)
AU (1) AU6006000A (en)
GB (1) GB9917384D0 (en)
WO (1) WO2001007022A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2744307A1 (en) * 2008-11-24 2010-05-27 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
GB201415598D0 (en) * 2014-09-03 2014-10-15 Univ Birmingham Elavated Itercranial Pressure Treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872447A (en) * 1958-12-23 1961-07-12 Lepetit Spa 1-carbamyl-3-substituted azetidines
DE69902142T2 (en) * 1998-01-23 2003-01-09 Vernalis Research Ltd., Winnersh AZETIDINE CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISEASES

Also Published As

Publication number Publication date
EP1196165A2 (en) 2002-04-17
AU6006000A (en) 2001-02-13
WO2001007022A2 (en) 2001-02-01
WO2001007022A3 (en) 2001-06-14
JP2003505413A (en) 2003-02-12

Similar Documents

Publication Publication Date Title
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
GB9903861D0 (en) Chemical compounds
GB9910104D0 (en) Chemical compounds
GB9910110D0 (en) Chemical compounds
GB9917386D0 (en) Chemical compounds-II
GB9917385D0 (en) Chemical compounds-I
GB9917384D0 (en) Chemical compounds-III
GB9914015D0 (en) Chemical compounds
GB9910394D0 (en) Chemical compounds
GB9910793D0 (en) Chemical processes
GB9910419D0 (en) Chemical compounds
GB9925837D0 (en) Chemical compounds -III
GB9925838D0 (en) Chemical compounds -II
GB9925839D0 (en) Chemical Compounds -I
GB9910405D0 (en) Chemical compounds
GB9909408D0 (en) Chemical compounds
GB9910672D0 (en) Chemical compounds
GB9910647D0 (en) Chemical compounds
GB9910421D0 (en) Chemical compounds
GB9910674D0 (en) Chemical compounds
GB9910417D0 (en) Chemical compounds
GB9910409D0 (en) Chemical compounds
GB9910675D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)